{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T18:48:12Z","timestamp":1776451692228,"version":"3.51.2"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070755, 82070595, 81972696, 81671973, 81860502, 31670761, 31872715 and 81773205"],"award-info":[{"award-number":["32070755, 82070595, 81972696, 81671973, 81860502, 31670761, 31872715 and 81773205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The prevalence of non-obese nonalcoholic fatty liver disease (NAFLD) is increasing worldwide with unclear etiology and pathogenesis. Here, we show GP73, a Golgi protein upregulated in livers from patients with a variety of liver diseases, exhibits Rab GTPase-activating protein (GAP) activity regulating ApoB export. Upon regular-diet feeding, liver-GP73-high mice display non-obese NAFLD phenotype, characterized by reduced body weight, intrahepatic lipid accumulation, and gradual insulin resistance development, none of which can be recapitulated in liver-GAP inactive GP73-high mice. Common and specific gene expression signatures associated with GP73-induced non-obese NAFLD and high-fat diet (HFD)-induced obese NAFLD are revealed. Notably, metformin inactivates the GAP activity of GP73 and alleviates GP73-induced non-obese NAFLD. GP73 is pathologically elevated in NAFLD individuals without obesity, and GP73 blockade improves whole-body metabolism in non-obese NAFLD mouse model. These findings reveal a pathophysiological role of GP73 in triggering non-obese NAFLD and may offer an opportunity for clinical intervention.<\/jats:p>","DOI":"10.1038\/s41467-021-27309-1","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T11:04:42Z","timestamp":1638356682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["GP73 is a TBC-domain Rab GTPase-activating protein contributing to the pathogenesis of non-alcoholic fatty liver disease without obesity"],"prefix":"10.1038","volume":"12","author":[{"given":"Yumeng","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4961-0171","authenticated-orcid":false,"given":"Qiang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0698-4077","authenticated-orcid":false,"given":"Luming","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enhao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huilong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1442-6179","authenticated-orcid":false,"given":"Xiaopan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linfei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haotian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangyue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changqin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhai","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuetao","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2886-3524","authenticated-orcid":false,"given":"Feixiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2128-9686","authenticated-orcid":false,"given":"Hui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3966-5507","authenticated-orcid":false,"given":"Congwen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"key":"27309_CR1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M. & Tsochatzis, E. A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65, 1038\u20131048 (2016).","journal-title":"Metabolism"},{"key":"27309_CR2","doi-asserted-by":"crossref","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","volume":"1","author":"EM Brunt","year":"2015","unstructured":"Brunt, E. M. et al. Nonalcoholic fatty liver disease. Nat. Rev. Dis. Prim. 1, 15080 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"27309_CR3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S2468-1253(20)30090-X","volume":"5","author":"M Eslam","year":"2020","unstructured":"Eslam, M., Fan, J. G. & Mendez-Sanchez, N. Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health. Lancet Gastroenterol. Hepatol. 5, 713\u2013715 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"27309_CR4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye, Q. et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 5, 739\u2013752 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"27309_CR5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","volume":"15","author":"D Kim","year":"2017","unstructured":"Kim, D. & Kim, W. R. Nonobese fatty liver disease. Clin. Gastroenterol. Hepatol. 15, 474\u2013485 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"27309_CR6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jhep.2007.06.020","volume":"47","author":"S Zelber-Sagi","year":"2007","unstructured":"Zelber-Sagi, S. et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J. Hepatol. 47, 711\u2013717 (2007).","journal-title":"J. Hepatol."},{"key":"27309_CR7","volume":"11","author":"G Lee","year":"2020","unstructured":"Lee, G. et al. Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD. Nat. Commun. 11, 4982 (2020).","journal-title":"Nat. Commun."},{"key":"27309_CR8","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","volume":"49","author":"L Miele","year":"2009","unstructured":"Miele, L. et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49, 1877\u20131887 (2009).","journal-title":"Hepatology"},{"key":"27309_CR9","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.3748\/wjg.v25.i24.3009","volume":"25","author":"JM Mato","year":"2019","unstructured":"Mato, J. M., Alonso, C., Noureddin, M. & Lu, S. C. Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. World J. Gastroenterol. 25, 3009\u20133020 (2019).","journal-title":"World J. Gastroenterol."},{"key":"27309_CR10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/ATVBAHA.111.241471","volume":"32","author":"S Tiwari","year":"2012","unstructured":"Tiwari, S. & Siddiqi, S. A. Intracellular trafficking and secretion of VLDL. Arterioscler. Thromb. Vasc. Biol. 32, 1079\u20131086 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"27309_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/bst0320059","volume":"32","author":"GF Gibbons","year":"2004","unstructured":"Gibbons, G. F., Wiggins, D., Brown, A. M. & Hebbachi, A. M. Synthesis and function of hepatic very-low-density lipoprotein. Biochem. Soc. Trans. 32, 59\u201364 (2004).","journal-title":"Biochem. Soc. Trans."},{"key":"27309_CR12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/hep.23094","volume":"50","author":"K Fujita","year":"2009","unstructured":"Fujita, K. et al. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology 50, 772\u2013780 (2009).","journal-title":"Hepatology"},{"key":"27309_CR13","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3389\/fonc.2019.00762","volume":"9","author":"K Takakura","year":"2019","unstructured":"Takakura, K. et al. Recent insights into the multiple pathways driving non-alcoholic steatohepatitis-derived hepatocellular carcinoma. Front Oncol. 9, 762 (2019).","journal-title":"Front Oncol."},{"key":"27309_CR14","doi-asserted-by":"crossref","first-page":"8543763","DOI":"10.1155\/2018\/8543763","volume":"2018","author":"O Kutlu","year":"2018","unstructured":"Kutlu, O., Kaleli, H. N. & Ozer, E. Molecular pathogenesis of nonalcoholic steatohepatitis- (NASH-) related hepatocellular carcinoma. Can. J. Gastroenterol. Hepatol. 2018, 8543763 (2018).","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"27309_CR15","doi-asserted-by":"crossref","first-page":"e1002217","DOI":"10.1371\/journal.pcbi.1002217","volume":"7","author":"Y Diekmann","year":"2011","unstructured":"Diekmann, Y. et al. Thousands of rab GTPases for the cell biologist. PLoS Comput. Biol. 7, e1002217 (2011).","journal-title":"PLoS Comput. Biol."},{"key":"27309_CR16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7555\/JBR.28.20140029","volume":"28","author":"RS Kiss","year":"2014","unstructured":"Kiss, R. S. & Nilsson, T. Rab proteins implicated in lipid storage and mobilization. J. Biomed. Res. 28, 169\u2013177 (2014).","journal-title":"J. Biomed. Res."},{"key":"27309_CR17","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/cbin.10650","volume":"40","author":"C Li","year":"2016","unstructured":"Li, C. & Yu, S. S. Rab proteins as regulators of lipid droplet formation and lipolysis. Cell Biol. Int. 40, 1026\u20131032 (2016).","journal-title":"Cell Biol. Int."},{"key":"27309_CR18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.celrep.2017.09.053","volume":"21","author":"CN Takacs","year":"2017","unstructured":"Takacs, C. N. et al. Differential regulation of lipoprotein and hepatitis C virus secretion by Rab1b. Cell Rep. 21, 431\u2013441 (2017).","journal-title":"Cell Rep."},{"key":"27309_CR19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ceb.2010.04.007","volume":"22","author":"F Barr","year":"2010","unstructured":"Barr, F. & Lambright, D. G. Rab GEFs and GAPs. Curr. Opin. Cell Biol. 22, 461\u2013470 (2010).","journal-title":"Curr. Opin. Cell Biol."},{"key":"27309_CR20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nature04847","volume":"442","author":"X Pan","year":"2006","unstructured":"Pan, X., Eathiraj, S., Munson, M. & Lambright, D. G. TBC-domain GAPs for Rab GTPases accelerate GTP hydrolysis by a dual-finger mechanism. Nature 442, 303\u2013306 (2006).","journal-title":"Nature"},{"key":"27309_CR21","first-page":"1139","volume":"11","author":"PM Richardson","year":"1995","unstructured":"Richardson, P. M. & Zon, L. I. Molecular cloning of a cDNA with a novel domain present in the tre-2 oncogene and the yeast cell cycle regulators BUB2 and cdc16. Oncogene 11, 1139\u20131148 (1995).","journal-title":"Oncogene"},{"key":"27309_CR22","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1600-0854.2007.00621.x","volume":"8","author":"C Bachert","year":"2007","unstructured":"Bachert, C., Fimmel, C. & Linstedt, A. D. Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma. Traffic 8, 1415\u20131423 (2007).","journal-title":"Traffic"},{"key":"27309_CR23","doi-asserted-by":"crossref","first-page":"e28207","DOI":"10.1371\/journal.pone.0028207","volume":"6","author":"L Hu","year":"2011","unstructured":"Hu, L., Li, L., Xie, H., Gu, Y. & Peng, T. The Golgi localization of GOLPH2 (GP73\/GOLM1) is determined by the transmembrane and cytoplamic sequences. PLoS ONE 6, e28207 (2011).","journal-title":"PLoS ONE"},{"key":"27309_CR24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1006\/viro.2002.1523","volume":"301","author":"RD Kladney","year":"2002","unstructured":"Kladney, R. D., Tollefson, A. E., Wold, W. S. & Fimmel, C. J. Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain. Virology 301, 236\u2013246 (2002).","journal-title":"Virology"},{"key":"27309_CR25","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.30549","volume":"70","author":"C Wei","year":"2019","unstructured":"Wei, C. et al. Tumor microenvironment regulation by the endoplasmic reticulum stress transmission mediator Golgi protein 73 in mice. Hepatology 70, 851\u2013870 (2019).","journal-title":"Hepatology"},{"key":"27309_CR26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1034\/j.1600-0854.2002.30906.x","volume":"3","author":"S Puri","year":"2002","unstructured":"Puri, S., Bachert, C., Fimmel, C. J. & Linstedt, A. D. Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption. Traffic 3, 641\u2013653 (2002).","journal-title":"Traffic"},{"key":"27309_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1152\/physrev.00059.2009","volume":"91","author":"AH Hutagalung","year":"2011","unstructured":"Hutagalung, A. H. & Novick, P. J. Role of Rab GTPases in membrane traffic and cell physiology. Physiol. Rev. 91, 119\u2013149 (2011).","journal-title":"Physiol. Rev."},{"key":"27309_CR28","first-page":"2996","volume":"128","author":"YS Lim","year":"2015","unstructured":"Lim, Y. S. & Tang, B. L. A role for Rab23 in the trafficking of Kif17 to the primary cilium. J. Cell Sci. 128, 2996\u20133008 (2015).","journal-title":"J. Cell Sci."},{"key":"27309_CR29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/exmp.2002.2449","volume":"73","author":"AP Kourounakis","year":"2002","unstructured":"Kourounakis, A. P. et al. Experimental hyperlipidemia and the effect of NSAIDs. Exp. Mol. Pathol. 73, 135\u2013138 (2002).","journal-title":"Exp. Mol. Pathol."},{"key":"27309_CR30","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena, G., Hardie, D. G. & Pearson, E. R. The mechanisms of action of metformin. Diabetologia 60, 1577\u20131585 (2017).","journal-title":"Diabetologia"},{"key":"27309_CR31","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/HJH.0000000000000532","volume":"33","author":"EC Aneni","year":"2015","unstructured":"Aneni, E. C. et al. Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk. J. Hypertens. 33, 1207\u20131214 (2015).","journal-title":"J. Hypertens."},{"key":"27309_CR32","volume":"7","author":"LN Tu","year":"2017","unstructured":"Tu, L. N. et al. Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice. Sci. Rep. 7, 6120 (2017).","journal-title":"Sci. Rep."},{"key":"27309_CR33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2045-3701-2-31","volume":"2","author":"HJ Kim","year":"2012","unstructured":"Kim, H. J., Lv, D., Zhang, Y., Peng, T. & Ma, X. Golgi phosphoprotein 2 in physiology and in diseases. Cell Biosci. 2, 31 (2012).","journal-title":"Cell Biosci."},{"key":"27309_CR34","doi-asserted-by":"crossref","first-page":"e12538","DOI":"10.1111\/cpr.12538","volume":"52","author":"Y Xia","year":"2019","unstructured":"Xia, Y. et al. Golgi protein 73 and its diagnostic value in liver diseases. Cell Prolif. 52, e12538 (2019).","journal-title":"Cell Prolif."},{"key":"27309_CR35","first-page":"6036904","volume":"2020","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. Serum Golgi protein 73 as a potential biomarker for hepatic necroinflammation in population with nonalcoholic steatohepatitis. Dis. Markers 2020, 6036904 (2020).","journal-title":"Dis. Markers"},{"key":"27309_CR36","doi-asserted-by":"crossref","unstructured":"Zheng, K. I. et al. Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels. BMJ Open Diabetes Res. Care 8, e001174 (2020).","DOI":"10.1136\/bmjdrc-2020-001174"},{"key":"27309_CR37","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1467-789X.2009.00642.x","volume":"11","author":"M Schreurs","year":"2010","unstructured":"Schreurs, M., Kuipers, F. & van der Leij, F. R. Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome. Obes. Rev. 11, 380\u2013388 (2010).","journal-title":"Obes. Rev."},{"key":"27309_CR38","doi-asserted-by":"crossref","unstructured":"Moreno-Fernandez, M. E. et al. Peroxisomal \u03b2-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease. JCI Insight 3, e93626 (2018).","DOI":"10.1172\/jci.insight.93626"},{"key":"27309_CR39","doi-asserted-by":"crossref","first-page":"15567","DOI":"10.1073\/pnas.0406901101","volume":"101","author":"B Chakravarty","year":"2004","unstructured":"Chakravarty, B., Gu, Z., Chirala, S. S., Wakil, S. J. & Quiocho, F. A. Human fatty acid synthase: structure and substrate selectivity of the thioesterase domain. Proc. Natl Acad. Sci. USA 101, 15567\u201315572 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"27309_CR40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1020550405578","volume":"239","author":"RA Weisiger","year":"2002","unstructured":"Weisiger, R. A. Cytosolic fatty acid binding proteins catalyze two distinct steps in intracellular transport of their ligands. Mol. Cell Biochem. 239, 35\u201343 (2002).","journal-title":"Mol. Cell Biochem."},{"key":"27309_CR41","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.90926.2008","volume":"297","author":"TY Chang","year":"2009","unstructured":"Chang, T. Y., Li, B. L., Chang, C. C. & Urano, Y. Acyl-coenzyme A:cholesterol acyltransferases. Am. J. Physiol. Endocrinol. Metab. 297, E1\u2013E9 (2009).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"27309_CR42","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1021\/acs.biochem.6b00342","volume":"55","author":"NM Cerqueira","year":"2016","unstructured":"Cerqueira, N. M. et al. Cholesterol biosynthesis: a mechanistic overview. Biochemistry 55, 5483\u20135506 (2016).","journal-title":"Biochemistry"},{"key":"27309_CR43","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.2337\/diabetes.51.8.2420","volume":"51","author":"SA Hawley","year":"2002","unstructured":"Hawley, S. A., Gadalla, A. E., Olsen, G. S. & Hardie, D. G. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51, 2420\u20132425 (2002).","journal-title":"Diabetes"},{"key":"27309_CR44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","volume":"15","author":"M Foretz","year":"2019","unstructured":"Foretz, M., Guigas, B. & Viollet, B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat. Rev. Endocrinol. 15, 569\u2013589 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"27309_CR45","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-020-2928-y","volume":"588","author":"XY Lu","year":"2020","unstructured":"Lu, X. Y. et al. Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis. Nature 588, 479\u2013484 (2020).","journal-title":"Nature"},{"key":"27309_CR46","volume":"11","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. Hepatic HuR modulates lipid homeostasis in response to high-fat diet. Nat. Commun. 11, 3067 (2020).","journal-title":"Nat. Commun."},{"key":"27309_CR47","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","volume":"17","author":"WL Holland","year":"2013","unstructured":"Holland, W. L. et al. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab. 17, 790\u2013797 (2013).","journal-title":"Cell Metab."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27309-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27309-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27309-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T12:42:31Z","timestamp":1699879351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27309-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["27309"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-27309-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]},"assertion":[{"value":"5 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7004"}}